US pharma major Eli Lilly, the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive top-line ...
The New Drug Application (NDA) for the combination of Elunate (fruquintinib) and TYVYT (sintilimab injection) has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results